Scattered radiation to gonads: Role of testicular shielding for para-aortic and homolateral illiac nodal radiotherapy
Background: Scattered radiation to organs at risk deserves great attention during radiotherapy especially when the concern is about fertility. Minimizing the delivery of scattered radiation to the gonads while treating abdominal nodes or pelvic fields in male patients requires adequate shielding of...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2014-06-01
|
| Series: | Journal of the Egyptian National Cancer Institute |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1110036214000223 |
| _version_ | 1818158628083859456 |
|---|---|
| author | Mukesh Kumar Singhal Akhil Kapoor Daleep Singh Puneet Kumar Bagri Satya Narayan Raj Kumar Nirban Harvindra Singh Kumar |
| author_facet | Mukesh Kumar Singhal Akhil Kapoor Daleep Singh Puneet Kumar Bagri Satya Narayan Raj Kumar Nirban Harvindra Singh Kumar |
| author_sort | Mukesh Kumar Singhal |
| collection | DOAJ |
| description | Background: Scattered radiation to organs at risk deserves great attention during radiotherapy especially when the concern is about fertility. Minimizing the delivery of scattered radiation to the gonads while treating abdominal nodes or pelvic fields in male patients requires adequate shielding of the testes to preserve testicular functions. We constructed a testicular shield with cerrobend for the purpose of treatment of seminoma of testis stage I and IIA disease.
Materials & methods: An outer shell of coconut of required dimensions was taken as a base over which cerrobend was poured to obtain two semi-spherical half testicular shields. Five patients of seminoma early stage (stage I and IIA) were treated with this testicular shield.
Results: The estimated total dose received by the testis by scatter radiation after completion of the treatment was 0.115 Gy (0.28%) of total mid-plane dose of 40 Gy delivered by inverted Y field. At a distance of 8 cm from the inferior field border the 2 cm thick cerrobend testicular shield provided a shielding factor of 3.2/0.3 = 10.33.
Conclusions: With proper testicular shielding, doses as low as 0.28% of the prescribed dose can be achieved. This low dose is believed to maintain the fertility of the patient. |
| first_indexed | 2024-12-11T15:33:06Z |
| format | Article |
| id | doaj.art-128404fc0f1b40c6a4e850eaa299d38d |
| institution | Directory Open Access Journal |
| issn | 1110-0362 |
| language | English |
| last_indexed | 2024-12-11T15:33:06Z |
| publishDate | 2014-06-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Journal of the Egyptian National Cancer Institute |
| spelling | doaj.art-128404fc0f1b40c6a4e850eaa299d38d2022-12-22T01:00:00ZengSpringerOpenJournal of the Egyptian National Cancer Institute1110-03622014-06-012629910110.1016/j.jnci.2014.03.002Scattered radiation to gonads: Role of testicular shielding for para-aortic and homolateral illiac nodal radiotherapyMukesh Kumar SinghalAkhil KapoorDaleep SinghPuneet Kumar BagriSatya NarayanRaj Kumar NirbanHarvindra Singh KumarBackground: Scattered radiation to organs at risk deserves great attention during radiotherapy especially when the concern is about fertility. Minimizing the delivery of scattered radiation to the gonads while treating abdominal nodes or pelvic fields in male patients requires adequate shielding of the testes to preserve testicular functions. We constructed a testicular shield with cerrobend for the purpose of treatment of seminoma of testis stage I and IIA disease. Materials & methods: An outer shell of coconut of required dimensions was taken as a base over which cerrobend was poured to obtain two semi-spherical half testicular shields. Five patients of seminoma early stage (stage I and IIA) were treated with this testicular shield. Results: The estimated total dose received by the testis by scatter radiation after completion of the treatment was 0.115 Gy (0.28%) of total mid-plane dose of 40 Gy delivered by inverted Y field. At a distance of 8 cm from the inferior field border the 2 cm thick cerrobend testicular shield provided a shielding factor of 3.2/0.3 = 10.33. Conclusions: With proper testicular shielding, doses as low as 0.28% of the prescribed dose can be achieved. This low dose is believed to maintain the fertility of the patient.http://www.sciencedirect.com/science/article/pii/S1110036214000223Testicular shieldingCerrobendPara aortic radiotherapyFertility |
| spellingShingle | Mukesh Kumar Singhal Akhil Kapoor Daleep Singh Puneet Kumar Bagri Satya Narayan Raj Kumar Nirban Harvindra Singh Kumar Scattered radiation to gonads: Role of testicular shielding for para-aortic and homolateral illiac nodal radiotherapy Journal of the Egyptian National Cancer Institute Testicular shielding Cerrobend Para aortic radiotherapy Fertility |
| title | Scattered radiation to gonads: Role of testicular shielding for para-aortic and homolateral illiac nodal radiotherapy |
| title_full | Scattered radiation to gonads: Role of testicular shielding for para-aortic and homolateral illiac nodal radiotherapy |
| title_fullStr | Scattered radiation to gonads: Role of testicular shielding for para-aortic and homolateral illiac nodal radiotherapy |
| title_full_unstemmed | Scattered radiation to gonads: Role of testicular shielding for para-aortic and homolateral illiac nodal radiotherapy |
| title_short | Scattered radiation to gonads: Role of testicular shielding for para-aortic and homolateral illiac nodal radiotherapy |
| title_sort | scattered radiation to gonads role of testicular shielding for para aortic and homolateral illiac nodal radiotherapy |
| topic | Testicular shielding Cerrobend Para aortic radiotherapy Fertility |
| url | http://www.sciencedirect.com/science/article/pii/S1110036214000223 |
| work_keys_str_mv | AT mukeshkumarsinghal scatteredradiationtogonadsroleoftesticularshieldingforparaaorticandhomolateralilliacnodalradiotherapy AT akhilkapoor scatteredradiationtogonadsroleoftesticularshieldingforparaaorticandhomolateralilliacnodalradiotherapy AT daleepsingh scatteredradiationtogonadsroleoftesticularshieldingforparaaorticandhomolateralilliacnodalradiotherapy AT puneetkumarbagri scatteredradiationtogonadsroleoftesticularshieldingforparaaorticandhomolateralilliacnodalradiotherapy AT satyanarayan scatteredradiationtogonadsroleoftesticularshieldingforparaaorticandhomolateralilliacnodalradiotherapy AT rajkumarnirban scatteredradiationtogonadsroleoftesticularshieldingforparaaorticandhomolateralilliacnodalradiotherapy AT harvindrasinghkumar scatteredradiationtogonadsroleoftesticularshieldingforparaaorticandhomolateralilliacnodalradiotherapy |